R3 Stem Cell Responds to FDA Letter to Reaffirm its Commitment to Public Health and Safety
- Thursday, June 6, 2019, 6:46
- Environment
- Add a comment
SCOTTSDALE, Ariz., June 6, 2019 /PRNewswire/ — R3 Stem Cell, LLC (R3), a leader in regenerative therapy practices, issued a formal response to a letter it received from the FDA that raised concerns over alleged unapproved stem cell products to treat a variety of diseases and conditions…
Source: https://www.prnewswire.com:443/news-releases/r3-stem-cell-responds-to-fda-letter-to-reaffirm-its-commitment-to-public-health-and-safety-300863248.html
About the Author
adminasapcorp has written 38955 stories on this site.